Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
May 16 2024 - 8:00AM
Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative
biopharmaceutical company focused on acquiring and advancing assets
to enhance long-term value for shareholders through product
revenue, equity holdings and dividend and royalty revenue, today
announced that Lindsay A. Rosenwald, M.D., Chairman, President and
Chief Executive Officer, will participate in a fireside chat at the
Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company
Showcase on Tuesday, May 21, 2024, at 4:20 p.m. ET.
Please click here to register for the
conference.
A replay of the fireside chat will be available
shortly after the conference on the Events page under the News
& Media section of Fortress’ website: www.fortressbiotech.com
for approximately 30 days following the meeting.
About Fortress BiotechFortress
Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical
company focused on acquiring and advancing assets to enhance
long-term value for shareholders through product revenue, equity
holdings and dividend and royalty revenue. The company has seven
marketed prescription pharmaceutical products and over 20 programs
in development at Fortress, at its majority-owned and
majority-controlled partners and subsidiaries and at partners and
subsidiaries it founded and in which it holds significant minority
ownership positions. Fortress’ portfolio is being commercialized
and developed for various therapeutic areas including oncology,
dermatology, and rare diseases. Fortress’ model is focused on
leveraging its significant biopharmaceutical industry expertise and
network to further expand and advance the company’s portfolio of
product opportunities. Fortress has established partnerships with
some of the world’s leading academic research institutions and
biopharmaceutical companies to maximize each opportunity to its
full potential, including AstraZeneca, City of Hope, Fred
Hutchinson Cancer Center, Nationwide Children’s Hospital and
Sentynl. For more information, visit www.fortressbiotech.com.
Company Contact:Jaclyn JaffeFortress Biotech,
Inc.(781) 652-4500ir@fortressbiotech.com
Media Relations Contact:Tony Plohoros6
Degrees(908) 591-2839tplohoros@6degreespr.com
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Aug 2023 to Aug 2024